section name header

Pronunciation ⬇

tye-ZAN-i-deen audio

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: Completely absorbed after oral administration but rapidly metabolized, resulting in 40% bioavailability.

Distribution: Widely distributed.

Metabolism/Excretion: 95% metabolized by the liver.

Half-life: 2.5 hr.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Exercise Extreme Caution in:

Adv. Reactions/Side Effects ⬆ ⬇

CNS: anxiety, depression, dizziness, sedation, weakness, dyskinesia, hallucinations, nervousness.

EENT: blurred vision, pharyngitis, rhinitis.

CV: hypotension, bradycardia.

GI: abdominal pain, diarrhea, dry mouth, dyspepsia, constipation, hepatocellular injury, ↑ liver enzymes, vomiting.

GU: urinary frequency.

Derm: rash, skin ulcers, sweating.

MS: back pain, myasthenia, paresthesia.

Misc: fever, speech disorder.

Interactions ⬆ ⬇

Drug-Drug:

Route/Dosage ⬆ ⬇

Tablets are not interchangeable with capsules

Implementation ⬆ ⬇

US Brand Names ⬆ ⬇

Zanaflex

Classifications ⬆ ⬇

Therapeutic Classification: antispasticity agents (centrally acting)

Pharmacologic Classification: adrenergics

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

(reduced muscle tone)

ROUTEONSETPEAKDURATION
POunknown1–2 hr3–6 hr

Assessment ⬆ ⬇

Lab Test Considerations:

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code*